• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定弥漫型胃癌淋巴结转移相关的基因组异常。

Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.

机构信息

Department of Physiology, Ajou University School of Medicine, Suwon, Republic of Korea.

Graduate School of Biomedical Science, Ajou University School of Medicine, Suwon, Republic of Korea.

出版信息

Exp Mol Med. 2018 Apr 6;50(4):1-11. doi: 10.1038/s12276-017-0009-6.

DOI:10.1038/s12276-017-0009-6
PMID:29622765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5938030/
Abstract

Diffuse-type gastric cancer (DGC) is a GC subtype with heterogeneous clinical outcomes. Lymph node metastasis of DGC heralds a dismal progression, which hampers the curative treatment of patients. However, the genomic heterogeneity of DGC remains unknown. To identify genomic variations associated with lymph node metastasis in DGC, we performed whole exome sequencing on 23 cases of DGC and paired non-tumor tissues and compared the mutation profiles according to the presence (N3, n = 13) or absence (N0, n = 10) of regional lymph node metastasis. Overall, we identified 185 recurrently mutated genes in DGC, which included a significant novel mutation at CMTM2, as well as previously known mutations at CDH1, RHOA, and TP53. Noticeably, CMTM2 expression could predict the prognostic outcomes of DGC but not intestinal-type GC (IGC), indicating pivotal roles of CMTM2 in DGC progression. In addition, we identified a recurrent loss of heterozygosity (LOH) of DNA copy numbers at the 3p12-pcen locus in DGC. A comparison of N0 and N3 tumors showed that N3 tumors exhibited more frequent DNA copy number aberrations, including copy-neutral LOH and mutations of CpTpT trinucleotides, than N0 tumors (P = 0.2 × 10). In conclusion, DGCs have distinct profiles of somatic mutations and DNA copy numbers according to the status of lymph node metastasis, and this might be helpful in delineating the pathobiology of DGC.

摘要

弥漫型胃癌(DGC)是一种临床结局具有异质性的 GC 亚型。DGC 的淋巴结转移预示着预后不良,这阻碍了患者的治愈性治疗。然而,DGC 的基因组异质性尚不清楚。为了鉴定与 DGC 淋巴结转移相关的基因组变异,我们对 23 例 DGC 及其配对的非肿瘤组织进行了全外显子测序,并根据是否存在(N3,n=13)或不存在(N0,n=10)区域淋巴结转移比较了突变图谱。总体而言,我们在 DGC 中鉴定了 185 个高频突变基因,包括 CMTM2 中的一个显著新突变,以及 CDH1、RHOA 和 TP53 中的先前已知突变。值得注意的是,CMTM2 的表达可以预测 DGC 的预后结果,但不能预测肠型 GC(IGC),表明 CMTM2 在 DGC 进展中起着关键作用。此外,我们在 DGC 中鉴定出 3p12-pcen 位点的 DNA 拷贝数缺失的反复发生。N0 和 N3 肿瘤的比较表明,N3 肿瘤比 N0 肿瘤表现出更频繁的 DNA 拷贝数异常,包括拷贝中性 LOH 和 CpTpT 三核苷酸的突变(P=0.2×10)。总之,根据淋巴结转移状态,DGC 具有不同的体细胞突变和 DNA 拷贝数谱,这可能有助于描绘 DGC 的病理生物学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/aa296ae59ceb/12276_2017_9_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/058fd36741e7/12276_2017_9_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/2b4637713f7d/12276_2017_9_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/d10c14544df9/12276_2017_9_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/561e8be3faac/12276_2017_9_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/aa296ae59ceb/12276_2017_9_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/058fd36741e7/12276_2017_9_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/2b4637713f7d/12276_2017_9_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/d10c14544df9/12276_2017_9_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/561e8be3faac/12276_2017_9_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0350/5938030/aa296ae59ceb/12276_2017_9_Fig5_HTML.jpg

相似文献

1
Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.鉴定弥漫型胃癌淋巴结转移相关的基因组异常。
Exp Mol Med. 2018 Apr 6;50(4):1-11. doi: 10.1038/s12276-017-0009-6.
2
Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.散发性早发性弥漫性胃癌中,体细胞CDH1改变的频率较高,但与晚发性癌症相比,体细胞RHOA突变的频率较低。
Gastroenterology. 2017 Aug;153(2):536-549.e26. doi: 10.1053/j.gastro.2017.05.012. Epub 2017 May 15.
3
CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.在墨西哥散发型和混合型散发性胃癌患者中检测到 CDH1 体突变。
BMC Cancer. 2019 Jan 14;19(1):69. doi: 10.1186/s12885-019-5294-0.
4
Genomic alterations in gastric cancers discovered via whole-exome sequencing.全外显子组测序发现的胃癌中的基因组改变。
BMC Cancer. 2018 Dec 19;18(1):1270. doi: 10.1186/s12885-018-5097-8.
5
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.胃腺癌进化中的多尺度异质性是精准医疗的障碍。
Genome Med. 2021 Nov 8;13(1):177. doi: 10.1186/s13073-021-00975-y.
6
Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.乳腺癌中与淋巴结转移相关的共存基因组异常。
J Clin Invest. 2018 Jun 1;128(6):2310-2324. doi: 10.1172/JCI97449. Epub 2018 Apr 23.
7
Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.胃癌的 TNM 分期和淋巴结转移与 MRI 特征及 VEGF 表达的相关性。
Cancer Biomark. 2018;23(1):53-59. doi: 10.3233/CBM-181287.
8
Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.弥漫型和肠型胃癌中FGFR1-4表达的不同临床意义。
World J Surg Oncol. 2017 Jan 5;15(1):2. doi: 10.1186/s12957-016-1081-4.
9
Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.化疗初治胆囊癌配对原发灶和同步转移淋巴结的突变全景。
Mol Biol Rep. 2022 Feb;49(2):1295-1301. doi: 10.1007/s11033-021-06957-y. Epub 2022 Jan 5.
10
Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.E-钙黏蛋白和 p53 在条件性转移性弥漫型胃癌小鼠模型中的协同肿瘤抑制活性。
Gut. 2012 Mar;61(3):344-53. doi: 10.1136/gutjnl-2011-300050. Epub 2011 Aug 24.

引用本文的文献

1
Comprehensive exome profiling identifies mutation as a driver in gastric cancer with ovarian metastasis.全外显子组分析确定突变是胃癌伴卵巢转移的驱动因素。
Theranostics. 2025 Jul 24;15(16):8202-8221. doi: 10.7150/thno.113382. eCollection 2025.
2
Comprehensive analysis of CMTM family and immune infiltration in esophageal carcinoma.食管癌中CMTM家族与免疫浸润的综合分析
PLoS One. 2025 Apr 3;20(4):e0321037. doi: 10.1371/journal.pone.0321037. eCollection 2025.
3
Analysis of biopsies of gastric cancer, intestinal and diffuse, and non-atrophic gastritis: an overview of loss of heterozygosity in Mexican patients.

本文引用的文献

1
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.利用1065例患者的转录组数据对胃癌生存相关生物标志物进行交叉验证。
Oncotarget. 2016 Aug 2;7(31):49322-49333. doi: 10.18632/oncotarget.10337.
2
Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.敲低CMTM3通过STAT3/Twist1/EMT信号通路促进胃癌转移。
Oncotarget. 2016 May 17;7(20):29507-19. doi: 10.18632/oncotarget.8789.
3
DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.
胃癌、肠型和弥漫型以及非萎缩性胃炎活检分析:墨西哥患者杂合性缺失概述
PeerJ. 2025 Feb 25;13:e18928. doi: 10.7717/peerj.18928. eCollection 2025.
4
Feasibility and Efficacy of Sentinel Lymph Node Mapping in Gastric Cancer.前哨淋巴结活检在胃癌中的可行性和疗效。
Ann Surg Oncol. 2024 Oct;31(10):6959-6969. doi: 10.1245/s10434-024-15642-w. Epub 2024 Aug 3.
5
Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.对趋化因子样因子(CKLF)样膜域包含家族(CMTM)的研究见解:它们在各种肿瘤中的作用。
PeerJ. 2024 Jan 10;12:e16757. doi: 10.7717/peerj.16757. eCollection 2024.
6
Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma.关于CMTM家族与肝细胞癌关系的当前观点
J Hepatocell Carcinoma. 2023 Aug 25;10:1411-1422. doi: 10.2147/JHC.S417202. eCollection 2023.
7
Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.胃腺癌进展过程中免疫和基质细胞状态及生态型的演变。
Cancer Cell. 2023 Aug 14;41(8):1407-1426.e9. doi: 10.1016/j.ccell.2023.06.005. Epub 2023 Jul 6.
8
Genomic mapping of metastatic organotropism in lung adenocarcinoma.肺腺癌转移器官倾向性的基因组图谱。
Cancer Cell. 2023 May 8;41(5):970-985.e3. doi: 10.1016/j.ccell.2023.03.018. Epub 2023 Apr 20.
9
Systematic Review and Meta-analysis of TP53, HER2/ERBB2, KRAS, APC, and PIK3CA Genes Expression Pattern in Gastric Cancer.胃癌中TP53、HER2/ERBB2、KRAS、APC和PIK3CA基因表达模式的系统评价与Meta分析
Middle East J Dig Dis. 2022 Jul;14(3):335-345. doi: 10.34172/mejdd.2022.292. Epub 2022 Jul 30.
10
Antitumor Effect of Si-Jun-Zi Decoction on SGC7901 Gastric Cancer Cells by CMTM2 Activation.四君子汤通过激活CMTM2对SGC7901胃癌细胞的抗肿瘤作用
Evid Based Complement Alternat Med. 2022 Jul 14;2022:4675815. doi: 10.1155/2022/4675815. eCollection 2022.
DeconstructSigs:剖析单个肿瘤中的突变过程可区分DNA修复缺陷和癌演变模式。
Genome Biol. 2016 Feb 22;17:31. doi: 10.1186/s13059-016-0893-4.
4
FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.FAT4通过调节Wnt/β-连环蛋白信号通路在胃癌中发挥肿瘤抑制作用。
Br J Cancer. 2015 Dec 22;113(12):1720-9. doi: 10.1038/bjc.2015.367. Epub 2015 Dec 3.
5
Loss of FAT Atypical Cadherin 4 Expression Is Associated with High Pathologic T Stage in Radically Resected Gastric Cancer.FAT 异常钙黏蛋白 4 表达缺失与根治性切除胃癌的高病理 T 分期相关。
J Gastric Cancer. 2015 Mar;15(1):39-45. doi: 10.5230/jgc.2015.15.1.39. Epub 2015 Mar 31.
6
Genomic profile analysis of diffuse-type gastric cancers.弥漫型胃癌的基因组图谱分析
Genome Biol. 2014 Apr 1;15(4):R55. doi: 10.1186/gb-2014-15-4-r55.
7
The emerging roles of ARID1A in tumor suppression.ARID1A 在肿瘤抑制中的新兴作用。
Cancer Biol Ther. 2014 Jun 1;15(6):655-64. doi: 10.4161/cbt.28411. Epub 2014 Mar 11.
8
Signatures of mutational processes in human cancer.人类癌症中的突变过程特征。
Nature. 2013 Aug 22;500(7463):415-21. doi: 10.1038/nature12477. Epub 2013 Aug 14.
9
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.食管腺癌的外显子组和全基因组测序鉴定出反复出现的驱动事件和突变复杂性。
Nat Genet. 2013 May;45(5):478-86. doi: 10.1038/ng.2591. Epub 2013 Mar 24.
10
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.检测不纯和异质癌症样本中的体细胞点突变。
Nat Biotechnol. 2013 Mar;31(3):213-9. doi: 10.1038/nbt.2514. Epub 2013 Feb 10.